canrenoic acid has been researched along with verapamil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altmann, O | 1 |
| Blengio, GS; Ciacciarelli, A; Corrocher, R; Falcone, S; Olivieri, O; Pizzolo, F; Signorelli, D | 1 |
2 other study(ies) available for canrenoic acid and verapamil
| Article | Year |
|---|---|
[Pharmacological lowering of portal pressure in normal rats and in experimental liver cirrhosis].
Topics: Acute Disease; Animals; Blood Pressure; Canrenoic Acid; Heart Rate; Hypertension, Portal; Liver Cirrhosis, Experimental; Male; Portal System; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Verapamil | 1991 |
Menopause not aldosterone-to-renin ratio predicts blood pressure response to a mineralocorticoid receptor antagonist in primary care hypertensive patients.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aldosterone; Blood Pressure; Canrenoic Acid; Female; Humans; Hypertension; Male; Menopause; Middle Aged; Mineralocorticoid Receptor Antagonists; Receptors, Mineralocorticoid; Renin; Verapamil | 2008 |